Search research articles
Contact Us
Filters
Showing results (291-300 of 350) with videos related to
Page
of 35
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda
Anna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
Eclinicalmedicine
|
March 2, 2026
Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trial
Eva Otoupalova, Lucas Ampaire, Megan Null, et al.
Journal of Clinical and Translational Science
|
November 30, 2023
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2
Nandini Avula, Dustin Kakach, Christopher J Tignanelli, et al.
The New England Journal of Medicine
|
September 21, 2023
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19
David R Boulware, Christopher J Lindsell, Thomas G Stewart, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 15, 2025
Etiology and Outcomes of Meningitis among Adults in Three Ugandan Referral Hospitals, 2018-2023: A Prospective Cohort Study in a High-HIV Endemic Setting
Timothy Mugabi, Suzan Namombwe, Biyue Dai, et al.
The Journal of Infectious Diseases
|
June 3, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death
Allyson Mateja, Eric Chu, Thomas A Murray, et al.
The Lancet. HIV
|
February 9, 2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial
Jayne Ellis, Gila Hale, Laura J Nsangi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2025
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial
Morris K Rutakingirwa, Caleb P Skipper, Biyue Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa
Melanie Moyo, David S Lawrence, James Jafali, et al.
Clinical and Translational Science
|
January 5, 2023
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials
Oriol Mitjà, Gilmar Reis, David R Boulware, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 350) with videos related to
Sort By:
Page
of 35
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda
Anna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
Eclinicalmedicine
|
March 2, 2026
Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trial
Eva Otoupalova, Lucas Ampaire, Megan Null, et al.
Journal of Clinical and Translational Science
|
November 30, 2023
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2
Nandini Avula, Dustin Kakach, Christopher J Tignanelli, et al.
The New England Journal of Medicine
|
September 21, 2023
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19
David R Boulware, Christopher J Lindsell, Thomas G Stewart, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 15, 2025
Etiology and Outcomes of Meningitis among Adults in Three Ugandan Referral Hospitals, 2018-2023: A Prospective Cohort Study in a High-HIV Endemic Setting
Timothy Mugabi, Suzan Namombwe, Biyue Dai, et al.
The Journal of Infectious Diseases
|
June 3, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death
Allyson Mateja, Eric Chu, Thomas A Murray, et al.
The Lancet. HIV
|
February 9, 2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial
Jayne Ellis, Gila Hale, Laura J Nsangi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2025
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial
Morris K Rutakingirwa, Caleb P Skipper, Biyue Dai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa
Melanie Moyo, David S Lawrence, James Jafali, et al.
Clinical and Translational Science
|
January 5, 2023
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials
Oriol Mitjà, Gilmar Reis, David R Boulware, et al.
Page
of 35